• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/22

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

22 Cards in this Set

  • Front
  • Back
Interstitial lung disease: History
Cough is a nearly universal symptom,
Wheezing suggests bronchiolitis or other concommitant airway pathology
-Usually no wheezing heard
Progressive or exertional dyspnea is a common manifestation of any diffuse or severe lung disease
Hemoptysis suggests vasculitis
Interstitial lung disease can result from occupational exposures
Interstitial lung disease: Physical exam
Crackles (rales) suggest interstitial lung disease or fibrosis;
-Inspiratory squeaks
Reduced volumes, basilar dullness
Pleural rub suggests pleurisy or pleuritis
Digital Clubbing is uncommon; and non-specific
Hypoxia or cor pulmonale is common with advanced disease of any type;
Interstitial lung disease: Imaging and lung function tests
Chest CT is the best imaging modality and is almost always done

Lung Function tests including arterial blood gas are most useful in measuring severity and estimating prognosis rather than making diagnoses
-Diffuse lung disease or pleural disease usually results in pulmonary restriction (reduced lung volumes)
-Airway involvement resulting in airflow obstruction is less common and suggests bronchiolitis or bronchiectasis
Interstitial lung disease: pathologic diagnosis
ILD can be diagnosed without surgical biopsy but precise classification usually requires a surgical biopsy
ILD often occur in association with connective tissue diseases
-Scleroderma
-Mixed-connective tissue disease
-Rheumatoid arthritis
-Polymyositis
-Lupus (SLE)
-Sjogren’s Disease (Sicca syndrome)
Pathophysiology of restrictive lung disease
Inflammation and fibrosis
-Decrease gas diffusion capacity

Compliance of lung decreases
Pulmonary function tests: results in ILD
Spirometry
-↓ Forced Expiratory Volume in 1 second (FEV1)
-↓ Forced Vital Capacity (FVC)
-↑ or normal FEV1/FVC Ratio

Lung volume measurements
-↓ Functional Residual Capacity (FRC) or Thoracic Gas Volume (TGV)
-↓ Total Lung Capacity (TLC)

Gas Diffusion measurements
-↓ DLCO
Pulmonary fibrosis, idiopathic pneumonias
Group of similar interstitial pneumonia with different histology subtypes
Pathogenesis of pulmonary fibrosis
Exposure/injury leads to inflammation

Body doesn't shut off inflammation when insult is gone

Also has abnormal remodeling and repair response

Inflammation leads to collagen deposition and fibroblastic focus
Idiopathic pulmonary fibrosis: prevalence, demographics, symptoms, signs
Prevalence estimate = 13-20 cases/100,000

Demographics
-Age of onset between 50-70 years old
-males > females
-More common in smokers

Symptoms
-Progressive dyspnea, cough for months to years (mean = 2 years)

Signs
-Velcro rales on exam (90%), cyanosis
Idiopathic pulmonary fibrosis: diagnosis
Gold Standard is Lung Biopsy

Diagnosis often made on clinical impression and imaging
Biopsy especially indicated for younger patients that do not present with class findings
Idiopathic pulmonary fibrosis: prognosis and treatment
Poor prognosis
-50% 5 year survival

Lung transplant:
-Probably the best therapeutic option
-Many patients are too old (> 65 years)
-Many have co-existing heart disease that makes them poor surgical candidates
-5 year survival for lung allografts is 60-70%
Non-specific interstitial pneumonia: clinical, findings, prognosis
Dyspnea, cough
Bilateral infiltrates or consolidation without much honeycombing
Occurs in association with hypersensitivity, resolving infection, collagen vascular disease
Prognosis better than UIP except for “fibrosing” NSIP
Desquamative Interstitial Pneumonitis and Respiratory Bronchiolitis Associated ILD (DIP/RBILD)
Usually associated with cigarette smoking
Cough and dyspnea
PFTs can show obstruction or restriction
Does not improve if cigarette smoking continues
Cryptogenic organizing pneumonia
Formerly BOOP, Bronchiolitis Obliterans Organizing Pneumonia
Airspace organizing pneumonia occurs in response to infection or other inflammation
Expected to respond to corticosteroids
Sarcoidosis: cause, demographics, symptoms, extrapulmonary symptoms
Idiopathic = Cause Unknown

Demographics
-20-40 years old
-females > males
-African Americans > Caucasians (8:1 in US)

Symptoms
-1/3 No symptoms (Abnormal Chest x-ray only)
-2/3 Dyspnea and dry cough

Extrapulmonary symptoms
-10% diagnosed from extrapulmonary sites
Organs involved in sarcoidosis
90% Lung or Abnormal Chest X-ray
75% Lymphadenopathy
30% Skin or erythema nodosum
25% Ocular mostly anterior uveitis
20% Liver and/or Spleen
17% Hypercalcemia (? mechanism)
5% Cardiac (high mortality, sudden death)
5% Central Nervous System
< 5% all others
Treatment in sarcoidosis
Asymptomatic patients
-Observe
Abnormal PFTs with no symptoms
-Observe and follow (PFT)
Pulmonary Symptoms
Severe restriction on PFTs
Fibrotic Chest X-ray
Persistent findings after 6 months observation
Ocular, Neurologic, Cardiac, Hypercalcemia
-Treat with Corticosteroids, Methotrexate, infliximab
Silicosis
Results from inflammation or fibrosis as a reaction to inhaled crystalline silica
Variable presentation: asymptomic with radiographic changes to progressive massive fibrosis and respiratory failure
“Silicotic nodule”
Birefringent particles seen on polarized microscopy
Many occupations exposed
Asbestosis
Pulmonary interstitial fibrosis from inhaled asbestos fibers
Variable presentation
Occupations: mining and manufacturing of asbestos products, insulators, shipyard workers, pipefitters (ships, power plants, refineries, seamen, steel workers)
Mesothelioma, pleural effusion
Coal workers pneumoconiosis
Less common with industrial hygeine practices
History is important
Variable presentation like for silicosis
“coal dust macule”
IPF, scleroderma, sarcoid, wegeners granulomatosis: treatment
IPF
-Transplant evaluation
Scleroderma
-Cyclophosphamide
Sarcoid
-Nothing, prednisone, methotrexate, infliximab
Wegener’s Granulomatosis
-Cyclophosphamide plus prednisone
Summary of ILD
History: Occupations, cough, dyspnea, chest pain
Crackles
Chest CT
PFTs: restrictive, low DLCO
Serologies (Antibodies) for vasculitis
Biopsy needed for definate diagnosis
Treatments: steroids, immunosuppressives, transplant